ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 7, 2024

Primary Completion Date

December 31, 2034

Study Completion Date

December 31, 2039

Conditions

Hepatocellular Carcinoma

Interventions

DRUG

RD-Cy7 fluorophore

Fluorophore targeting ITGA6 that is overexpressed in HCC cells

Trial Locations (2)

RECRUITING

Guangdong, Guangzhou

RECRUITING

Sichuan, Luzhou

All Listed Sponsors

lead

Institute of Automation, Chinese Academy of Sciences

OTHER